Pulmonary giant chondromatous hamartoma with multifocal evolution in an infant

Charlotte Bailly1,2, Arnauld Verschuur1,3, Emmanuelle Bosdure2

  • 1Department of Pediatric Hematology-Oncology, Timone Children's Hospital, Marseille, France.

Pediatric Blood & Cancer
|September 24, 2019
PubMed

Insights

Giant pulmonary chondromatous hamartoma is rare in children. This case highlights a rapidly progressive, multifocal lesion in an infant unresponsive to cytotoxic therapies, with no identified underlying syndrome.

Area of Science:

  • Pediatric Pulmonology
  • Pediatric Oncology
  • Thoracic Surgery

Background:

  • Pulmonary hamartomas are typically benign and common in adults, but rare in pediatric populations.
  • Giant chondromatous and rapidly progressive forms represent extremely rare subtypes.

Observation:

  • A 13-month-old infant presented with a rapidly progressive, giant pulmonary chondromatous hamartoma.
  • The condition manifested as severe, multifocal lesions discovered during a septic episode.
  • The infant showed no clear response to multiple cytotoxic therapies.

Findings:

  • This case represents a novel occurrence of giant pulmonary chondromatous hamartoma in an infant.
  • The tumor's rapid progression and multifocal nature are unusual features.
  • Absence of a predisposing syndrome was noted.

Implications:

  • This case expands the understanding of rare pediatric lung tumors.
  • It underscores the challenges in treating aggressive pulmonary hamartomas in infants.
  • Further research into novel therapeutic strategies for such rare conditions is warranted.